CC - Nipro TRUE METRIX meters receive FDA 510(k) clearance –
Florida-based Nipro Diagnostics announced that its TRUE METRIX and TRUE METRIX PRO Professional meters received FDA 510(k) clearance following a seven-month application review late last month. The TRUE METRIX will be marketed beginning in 4Q14 through retail, mail, and distribution channels under partner brands (e.g., CVS, Walgreens, Walmart) and Nipro’s own TRUE brand; no launch details were provided regarding the TRUE METRIX PRO. The press release highlights that both meters exceed the most recent 2013 ISO standards for SMBG, perhaps combatting perceptions that Nipro’s store-brand meters are not as accurate as branded offerings. The company states that it is the largest US manufacturer of diabetes products for the store brand market. The TRUE METRIX is already advertised on Nipro’s website, though pricing information has yet to be disclosed; we assume it will be priced comparably to current Nipro offerings, which on Amazon are ~$10 for meters and ~$19 for 100 strips – quite inexpensive at $0.20 per strip. Regarding reimbursement, most private insurance plans, Medicare Part B, and most Medicaid plans are expected to cover the device and strips, though dialogue with payers remains ongoing. The TRUE METRIX announcement also revealed Nipro’s plans to expand manufacturing capabilities in response to “six consecutive years of double-digit test strip growth.” Per Perrigo’s F4Q14 financial update, we understand that retail US diabetes care sales rose 7% YOY in store brands vs. a 9% decline among national brands – a good sign for Nipro’s business though certainly negative for the Big Four (J&J, Abbott, Bayer, and Roche).